The telecom-media giant that would be formed if federal regulators approve AT&T $85.4 billion purchase of Time Warner raises antitrust issues, Democratic vice presidential candidate Tim Kaine and several US lawmakers said on Sunday.
Kaine said lawmakers and regulators would have to review the deal and “get to the bottom” of questions over whether the merger would decrease competition.
“I’m pro-competition,” Kaine said on NBC’s “Meet the Press.” “Less concentration, I think, is generally helpful especially in the media.”
Kaine, Democratic presidential candidate Hillary Clinton’s running mate, said he had not had a chance to review the details of the deal. The Clinton campaign did not respond to a request for comment.
Republican presidential candidate Donald Trump said at a rally on Saturday after the deal was announced that he would block it if he wins the Nov. 8 election against Democrat Hillary Clinton.
“It’s too much concentration of power in the hands of too few,” said Trump, who has accused the media of being biased against him and his campaign.
The US Justice Department, not the president, has the power to reject such a deal if it violates antitrust laws. AT&T said it is unclear if the Federal Communications Commission will have jurisdiction to review the deal.
Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Orders Apple to Address Fortnite App Block or Face Court Hearing
May 19, 2025 by
CPI
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas